Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep vein thrombosis (DVT) and pulmonary embolism. Unfortunately, hundreds of patients who have taken the drug have experience negative side effects, including uncontrollable internal bleeding that has no antidote. 

One recent study, led by doctors Judy H. Hun and John C. Hwang, linked usage of the drug to an increased incidence of spontaneous vitreous hemorrhage, or eye bleeding, and noted that it was most notable when patients switched from one blood thinner to Xarelto. A second study compared the safety of Xarelto and Pradaxa to warfarin, the more traditional anticoagulant in the market today. Their study suggested a link between Xarelto and Pradaxa usage to a 50% increased risk of gastrointestinal bleeding. There are more than 500 Xarelto-related lawsuits pending in consolidated state and federal courts.

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.